Benutzerspezifische Werkzeuge

Kopf-Hals-Tumoren

Kopf-Hals: ICT01-101

A first-in-human, two-part, open-label, clinical study to assess the saftey, tolerability and activity of intravenous doses of ICT01 as monotherapy and in combination with an immune checkpoint inhibitor, in patients with advanced-stage, relapsed/ refractory cancer (EVICTION ...Mehr…